Twitter Beğeni Hilesi

This is very compelling data, of course OS data is necessary but a new key contender enters the race 💥 Summit Therapeutics #ivonescimab #NSCLC #WCLC24

🚦I-DXd is active but potentially lethal for patients with SCLC. ⚠️ 12 mg/kg vs 8 mg/kg: ⬆️ ORR 55% vs 26% , similar PFS and OS, and encouraging 🧠 activity. ☠️Sorry to hear is manejable toxicity: 10 % ILD 🩻, and 14% vs 7 % of toxic deaths ‼️#WCLC24 #LCSM

The streets of Gaslamp Quarter getting ready for us…❤️❤️❤️❤️ I plan to wear my comfortable shoes and dance with my friends tonight… See you all there! IASLC #WCLC2024 #IASLC50 OncLive.com #LCSM Chat

50th @iaslc anniversary history plenary going on now! Grab your copy of the @iaslc history by print or as PDF my.iaslc.org/s/store#/store…

#WCLC24 Celebrating 50 years of IASLC building community , friendships, collaboration to advance #lungcancer research #lcsm #IASLC50

#WCLC24 #IASLC50 After party 🎉

💊 It seems like we have two new “osimertinibs” for HER2 mutations. BAY 2927088 and Zongertinib hit the 70% response rate threshold with an acceptable toxicity profile. Already ph3 trials in 1st line HER2mut NSCLC ongoing. Competitive indication with Trastu-DXd. #WCLC24 #LCSM

Dr. Dr. Antonio Calles 🫁🚭 reviews #HER2 and #HER3 #ADCs in NSCLC. Beautiful visual and explanation of bystander effect. #wclc24 IASLC #lcsm

Dr. Dr. Antonio Calles 🫁🚭 summarizes HER3 ADCs at #WCLC24. I like the versatility and efficacy across resistance mechanisms but would benefit from a biomarker - HER3 expression alone isn’t it.

Dr. Joshua Reuss at the podium at #WCLC24 with great perspective on the potential of ADCs including how TROP2 ADCs will have an impact in the treatment of pts with NSCLC.

Dr. Joshua Reuss presenting the data on #CEACAM, #MET, and #TROP2 #ADCs. Many great questions we still have yet to answers here. #lcsm IASLC #wclc24

Excellent speakers and chairs for the ADC education session. #WCLC24

Big congratulations to Dr. Luis Paz-Ares - the 2024 Heine H. Hansen Lectureship Award for Small Cell Lung Cancer! A brilliant investigator, compassionate clinician, gifted speaker, and a friend to us all. #WCLC24

#ESMO24 numbers 🔥 ESMO - Eur. Oncology

🩹Are you a HCP? Have you ever received in your inbox any of these emails? Is all your institution can do to prevent burn-out, mental health or suicide? Have you ever openly spoken to your colleagues or asked for help? Follow #ESMO4Carers for #ProfessionalWellbeing #ESMO24